4 papers
Transplantation represents one of medicine's most profound triumphs, offering life-saving second chances to patients with failing organs. This rapidly evolving field explores everything from improving donor-organ compatibility and reducing rejection risks to pioneering regenerative techniques that could one day eliminate the waiting list entirely.
On Gist.Science, we track every new preprint in this category as it emerges from medRxiv. Our team processes each study to provide both detailed technical breakdowns for experts and clear, plain-language summaries that make complex immunology and surgical advancements accessible to everyone. Whether you are a clinician staying current or a curious reader, these insights bridge the gap between raw data and real-world impact.
Below are the latest papers on transplantation, freshly summarized and ready for your review.
This paper reports a second multistate tuberculosis outbreak linked to a bone allograft product, highlighting critical gaps in current donor screening and tissue testing protocols that failed to detect *Mycobacterium tuberculosis* until after the outbreak occurred, resulting in significant morbidity and mortality among recipients.
This economic evaluation of deceased donor organ transplantation in the UK concludes that while kidney transplants are cost-saving compared to dialysis, heart and liver transplants are cost-effective within standard thresholds, whereas lung transplants remain the least cost-effective option.
A retrospective cohort study of two donor hospitals that switched Organ Procurement Organization (OPO) affiliations found that the change led to statistically significant increases in organ donors and transplants driven by improved donor conversion, suggesting that realigning hospital-OPO relationships can enhance donation activity without negatively impacting the system.
This multicenter prospective study of 185 kidney transplant recipients found that [18F]FDG PET/CT imaging, measured by mean standardized uptake value ratios, fails to reliably detect or rule out subclinical acute rejection in stable patients at three months post-transplantation.